FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591531332> ?p ?o ?g. }

• W2591531332 endingPage "27092" @default.
• W2591531332 startingPage "27075" @default.
• W2591531332 abstract "Glycans containing α-L-fucose participate in diverse interactions between cells and extracellular matrix. High glycan expression on cell surface is often associated with neoplastic progression. The lysosomal exoenzyme, α-L-fucosidase-1 (FUCA-1) removes fucose residues from glycans. The FUCA-1 gene is down-regulated in highly aggressive and metastatic human tumors. However, the role of FUCA-1 in tumor progression remains unclear. It is speculated that its inactivation perturbs glycosylation of proteins involved in cell adhesion and promotes cancer. FUCA-1 expression of various thyroid normal and cancer tissues assayed by immunohistochemical (IHC) staining was high in normal thyroids and papillary thyroid carcinomas (PTC), whereas it progressively decreased in poorly differentiated, metastatic and anaplastic thyroid carcinomas (ATC). FUCA-1 mRNA expression from tissue samples and cell lines and protein expression levels and enzyme activity in thyroid cancer cell lines paralleled those of IHC staining. Furthermore, ATC-derived 8505C cells adhesion to human E-selectin and HUVEC cells was inhibited by bovine α-L-fucosidase or Lewis antigens, thus pointing to an essential role of fucose residues in the adhesive phenotype of this cancer cell line. Finally, 8505C cells transfected with a FUCA-1 containing plasmid displayed a less invasive phenotype versus the parental 8505C. These results demonstrate that FUCA-1 is down-regulated in ATC compared to PTC and normal thyroid tissues and cell lines. As shown for other human cancers, the down-regulation of FUCA-1 correlates with increased aggressiveness of the cancer type. This is the first report indicating that the down-regulation of FUCA-1 is related to the increased aggressiveness of thyroid cancer." @default.
• W2591531332 created "2017-03-03" @default.
• W2591531332 creator A5008698979 @default.
• W2591531332 creator A5012693105 @default.
• W2591531332 creator A5035771083 @default.
• W2591531332 creator A5039771085 @default.
• W2591531332 creator A5039839193 @default.
• W2591531332 creator A5051690707 @default.
• W2591531332 creator A5052914371 @default.
• W2591531332 creator A5060754049 @default.
• W2591531332 creator A5060902293 @default.
• W2591531332 creator A5074704114 @default.
• W2591531332 creator A5080374621 @default.
• W2591531332 date "2017-02-23" @default.
• W2591531332 modified "2023-10-18" @default.
• W2591531332 title "Human<i>α-L-fucosidase-1</i>attenuates the invasive properties of thyroid cancer" @default.
• W2591531332 cites W1182461782 @default.
• W2591531332 cites W1495692159 @default.
• W2591531332 cites W1585615821 @default.
• W2591531332 cites W1732802738 @default.
• W2591531332 cites W1772100314 @default.
• W2591531332 cites W178000426 @default.
• W2591531332 cites W1839290653 @default.
• W2591531332 cites W1840340050 @default.
• W2591531332 cites W1911261579 @default.
• W2591531332 cites W1969834815 @default.
• W2591531332 cites W1970792779 @default.
• W2591531332 cites W1972126018 @default.
• W2591531332 cites W1978352632 @default.
• W2591531332 cites W1981975876 @default.
• W2591531332 cites W1991662589 @default.
• W2591531332 cites W1992833735 @default.
• W2591531332 cites W1997302006 @default.
• W2591531332 cites W1997668120 @default.
• W2591531332 cites W2000973093 @default.
• W2591531332 cites W2008545486 @default.
• W2591531332 cites W2017001178 @default.
• W2591531332 cites W2019579423 @default.
• W2591531332 cites W2024281238 @default.
• W2591531332 cites W2032385327 @default.
• W2591531332 cites W2034195559 @default.
• W2591531332 cites W2045945348 @default.
• W2591531332 cites W2047216324 @default.
• W2591531332 cites W2052400927 @default.
• W2591531332 cites W2057049168 @default.
• W2591531332 cites W2060205349 @default.
• W2591531332 cites W2074631785 @default.
• W2591531332 cites W2083260383 @default.
• W2591531332 cites W2091309870 @default.
• W2591531332 cites W2110493163 @default.
• W2591531332 cites W2117946498 @default.
• W2591531332 cites W2119644508 @default.
• W2591531332 cites W2121524318 @default.
• W2591531332 cites W2123944316 @default.
• W2591531332 cites W2125323309 @default.
• W2591531332 cites W2130280698 @default.
• W2591531332 cites W2133382041 @default.
• W2591531332 cites W2133627613 @default.
• W2591531332 cites W2152116918 @default.
• W2591531332 cites W2161412157 @default.
• W2591531332 cites W2169864898 @default.
• W2591531332 cites W2186338351 @default.
• W2591531332 cites W2227831008 @default.
• W2591531332 cites W2304981697 @default.
• W2591531332 cites W2311800161 @default.
• W2591531332 cites W2338518322 @default.
• W2591531332 cites W2398790745 @default.
• W2591531332 cites W2402692616 @default.
• W2591531332 cites W2404986433 @default.
• W2591531332 cites W2411781146 @default.
• W2591531332 cites W2434524091 @default.
• W2591531332 cites W2464424134 @default.
• W2591531332 doi "https://doi.org/10.18632/oncotarget.15635" @default.
• W2591531332 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5432319" @default.
• W2591531332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28404918" @default.
• W2591531332 hasPublicationYear "2017" @default.
• W2591531332 type Work @default.
• W2591531332 sameAs 2591531332 @default.
• W2591531332 citedByCount "22" @default.
• W2591531332 countsByYear W25915313322017 @default.
• W2591531332 countsByYear W25915313322018 @default.
• W2591531332 countsByYear W25915313322019 @default.
• W2591531332 countsByYear W25915313322020 @default.
• W2591531332 countsByYear W25915313322021 @default.
• W2591531332 countsByYear W25915313322022 @default.
• W2591531332 countsByYear W25915313322023 @default.
• W2591531332 crossrefType "journal-article" @default.
• W2591531332 hasAuthorship W2591531332A5008698979 @default.
• W2591531332 hasAuthorship W2591531332A5012693105 @default.
• W2591531332 hasAuthorship W2591531332A5035771083 @default.
• W2591531332 hasAuthorship W2591531332A5039771085 @default.
• W2591531332 hasAuthorship W2591531332A5039839193 @default.
• W2591531332 hasAuthorship W2591531332A5051690707 @default.
• W2591531332 hasAuthorship W2591531332A5052914371 @default.
• W2591531332 hasAuthorship W2591531332A5060754049 @default.
• W2591531332 hasAuthorship W2591531332A5060902293 @default.
• W2591531332 hasAuthorship W2591531332A5074704114 @default.
• W2591531332 hasAuthorship W2591531332A5080374621 @default.

• next